Colon Capsule Endoscopy in Children (VICCOINBODI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02129972|
Recruitment Status : Completed
First Posted : May 2, 2014
Last Update Posted : July 15, 2019
The incidence of Inflammatory Bowel Diseases (IBD) is in a continuous progression both in adults as in children. The colonoscopy is considered as the gold standard exam for the diagnosis and the follow-up of the patients presenting or suspected to have an IBD. The follow-up and financial management of this kind of pathology is very much dependent on the quality of the endoscopic images. Because colonoscopy is an expensive and invasive technique which assumes a general sedation, many efforts have been done to develop new less expensive and less invasive techniques in order to offer alternatives to the classic colon endoscopy. One of these new techniques is the colon videocapsule (CVC) endoscopy (PillCam® colon 2 - Given Imaging, Yoqneam, Israel). This is a new promising semi-invasive endoscopic technique which has been successfully validated with adults. We hypothesize that the CVC can be used in children with similar results in terms of efficacy, as is the case for adults.
This prospective simple blind multicenter study, will investigate the diagnostic value of the CVC compared to the conventional colonoscopy under general sedation for the detection and the control of colon lesions in children presenting IBD.
If the feasibility and the efficacy of the colon video capsule technique are also proven for use with children, then this new technique might become a very interesting alternative for the endoscopic examination of the colon because of being less expensive and less invasive.
Moreover, this technique would be very useful as a means of lesions detection all along the digestive tract and not limited to the colon only.
|Condition or disease||Intervention/treatment||Phase|
|Inflammatory Bowel Disease||Device: Colon videocapsule endoscopy (PillCam colon 2)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||52 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Evaluation of the Video Capsule Colonoscopy for the Detection and the Control of Colon Lesions in Children Presenting Confirmed or Suspected Inflammatory Bowel Disease|
|Actual Study Start Date :||April 2014|
|Actual Primary Completion Date :||April 2018|
|Actual Study Completion Date :||April 2018|
|Experimental: video capsule endoscopy||
Device: Colon videocapsule endoscopy (PillCam colon 2)
This is a simple blind (blind for the lecture of the CVC record) study to evaluate the diagnostic value of the colon capsule endoscopy for the detection and the control of colon lesions, the feasibility, tolerance and safety of the CVC compared to the conventional colonoscopy under general sedation in children presented with Inflammatory Bowel Disease.
Over one week, the patient will undergo two exams (CVC and colonoscopy under general sedation). The exams will be done by two different physicians.
In order to assess the tolerance, after the completion of both exams, the patients will be asked to answer a "comfort score" questionnaire.
In order to assess the safety of the CVC, the patients will have a follow-up for adverse events over a 3 weeks period after completion of the CVC and only if the colon video capsule was not recovered during the conventional colonoscopy.
Other Name: PillCam colon 2
- The diagnostic value of the wireless colon capsule endoscopy [ Time Frame: 1 week after the completion of the colon video capsule exam . ]The diagnostic value of the colon video capsule will be estimated based upon the calculated sensitivity of the colon video capsule for the detection and the control of colon lesions in children presented with IBD compared to the colonoscopy sensitivity.
- Diagnostic and predictive value of the colon video capsule [ Time Frame: 1 week after the completion of the colon video capsule exam ]The diagnostic value expressed by the specificity, positive and negative predictive values of the colon video capsule compared to the results of the colonoscopy under general sedation.
- Diagnostic performance of the colon video capsule [ Time Frame: 1 week after the completion of both endoscopic exams ]Percentage of the colon lesions successfully detected by the colon video capsule compared to the results recorded during the colonoscopy.
- Evaluation of the feasibility and the acceptability by the patient of the colon video capsule compared to the colonoscopy under general sedation [ Time Frame: 1 week after the completion of the colon video capsule exam ]Based upon the comfort score calculated after a comfort questionnaire that the patient has been completed after the colon video capsule exam and colonoscopy have been performed
- Evaluation of the efficacy of the bowel preparation before the endoscopic examination of the colon [ Time Frame: 1 week after the colon video capsule has been performed ]The evaluation will be done using the Boston score.
- Descriptive analysis of the visualization and the progression of the colon video capsule over the different segments of the bowel [ Time Frame: 1 week after the colon video capsule has been performed ]The analysis will be based upon the description of the different lesions and the time of capsule progression in each bowel segment during the video capsule exam. The different segments will be defined taking into account the anatomic landmarks.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02129972
|Service de Pédiatrie Médicale, Hôpital Pellegrin, CHU de Bordeaux|
|Service d'Hépatologie, gastroentérologie et nutrition pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon|
|Clinique de Pédiatrie, Hôpital Jeanne de Flandre, CHU de Lille|
|Service de Gastroentérologie, Mucoviscidose et Nutrition, Hôpital Robert Debré, AP-HP|
|Service de Hépato Gastroentérologie et Nutrition, Hôpital Necker Enfants Malades, AP-HP|
|Service de Pédiatrie, Hôpital Sud, CHU de Rennes|
|Service de Gastroentérologie, Hépatologie, Nutrition et Diabétologie, Hôpital des Enfants, CHU de Toulouse|
|Principal Investigator:||ALAIN LACHAUX, MD||HOPITAL FEMME MERE ENFANT CHU DE LYON|